Table 1.
Patient characteristics and drugs administered for them
| Parameters, drugs and intervention (%) | Placebo group (n = 20) | Pentoxifylline group (n = 20) |
|---|---|---|
| Age (year) | 53.62 ± 9.19 | 55.46 ± 7.69 |
| Sex M/F | 85/15 | 75/25 |
| Smoking | 50 | 30 |
| Hypertension | 30 | 30 |
| Hyperlipidemia | 25 | 25 |
| Chest pain | 55 | 25 |
| Involved in CABG | 45 | 30 |
| Involved in PCI | 30 | 55 |
| Plaque in LAD | 75 | 75 |
| Plaque in RCA | 15 | 40 |
| Plaque in Cx | 10 | 45 |
| TVD | 25 | 15 |
| Hypothyroidism | 10 | 0 |
| Ejection fraction | 51.46 ± 8.33 | 52.33 ± 8.63 |
There is no significant (P>0.05) difference between two groups after statistical analysis (Chi-square/student's t-test) except in case of chest pain (P<0.05); CABG, coronary artery bypass graft surgery; PCI, percutaneous coronary intervention; LAD, left anterior descending-coronary artery; RCA, right coronary artery; Cx, circumflex coronary artery; TVD, triple vessel disease